Publication | Closed Access
Phase II radioimmunotherapy trial with131I-CC49 in colorectal cancer
88
Citations
25
References
1994
Year
Despite minimal toxicity and favorable tumor uptake, efficacy has been limited at this dose and schedule.
| Year | Citations | |
|---|---|---|
Page 1
Page 1